Irinotecan and Anlotinib for Epithelioid Sarcoma

Clinical trial NCT05656222 · WITHDRAWN

Trial details

NCT number: NCT05656222
Sponsor: Peking University People's Hospital
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Objective Response Overall Survival

Start date: 2021-08-01
Primary completion: 2024-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.